Claims
- 1. A method of removing beta-2 microglobulin from blood, comprising the steps of removing blood from a patient, passing the blood through an adsorbent material with a size and a structure selected so as to remove beta-2 microglobulin from the blood, and re-entering the blood from which the beta-2 microglobulin is removed into the patient, wherein said material is a porous beaded polydivinylbenzene or polystyrene-co-polydivinylbenzene polymer with a surface of beads and of pores modified so as to prevent adsorption of large proteins and platelets and to minimize activation of blood complement system without affecting noticeably accessibility of an inner absorption space of the beads for beta-2 microglobulin and middle-sized toxicant molecules, in which polymer surface exposed vinyl groups are chemically modified so as to form different surface exposed functional groups with a greater hydrophilicity and greater biocompatibility than those of the vinyl groups, so that during contact of blood with the material the beaded polymer provides adsorption of beta-2 microglobulin while the different surface exposed functional groups provide the biocompatibility of the material.
- 2. A method of removing beta-2 microglobulin from blood as defined in claim 1, wherein said passing the blood through said adsorbing material takes place simultaneously with a conventional hemodialysis procedure where the blood is forced to pass also through a hemodialysis membrane cartridge.
- 3. A method of removing beta-2 microglobulin from blood as defined in claim 1, wherein said passing the blood through said adsorbing material takes place in sequence with a conventional hemodialysis procedure where the blood is forced to pass also through the hemodialysis membrane cartridge.
- 4. A method as defined in claim 1, wherein said passing includes passing through the adsorbent material which is porous polydivinylbenzene or polystyrene-co-polydivinylbenzene polymer.
- 5. A method as defined in claim 4, wherein said polymer has an enhanced portion of mesopores.
CROSS-REFERENCE TO A RELATED APPLICATION
This application is a continuation-in-part of patent application Ser. No. 08/902,727 filed on Jul. 30, 1997, now U.S. Pat. No. 5,904,663.
US Referenced Citations (5)
Number |
Name |
Date |
Kind |
5051185 |
Watanabe et al. |
Sep 1991 |
A |
5073265 |
Johnson et al. |
Dec 1991 |
A |
5403750 |
Braatz et al. |
Apr 1995 |
A |
5773384 |
Davankov et al. |
Jun 1998 |
A |
5904663 |
Braverman et al. |
May 1999 |
A |
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
08/902727 |
Jul 1997 |
US |
Child |
09/294224 |
|
US |